药物对比
Exenatide vs Insulin Degludec
比较 Exenatide（Byetta/Bydureon）与 Insulin Degludec（Tresiba）治疗糖尿病：GLP-1受体激动剂与基础胰岛素、给药方案、对体重的影响及低血糖风险。
此页面暂无可用的对比维度。
临床背景
This comparison arises when adding injectable therapy after oral agents fail in type 2 diabetes, deciding between GLP-1 agonist and basal insulin intensification.
结论
The preferred option is individualized, with Exenatide favored for earlier weight-focused therapy and Insulin Degludec for advanced basal coverage needs.
全部药物对比